Technical Analysis for AMEUF - Admedus

Admedus Limited, a healthcare company, develops, commercializes, and distributes next generation medical technologies and devices. The company is involved in the process of commercializing its tissue engineering technology for regenerative medicine. It provides CardioCel, a cardiovascular scaffold for the repair of congenital heart deformities and heart defects, as well as for the reconstruction of dysfunctional heart valves and valve leaflets; and VascuCel, a collagen scaffold used in cardiac repairs and reconstructions. The company also offers administration accessories, including V-Set that connects patient's port or cannula via a luer lock fitting to provide multiple line access to a single site; and Eldor for the delivery of medication, such as local anesthetic. In addition, it provides ambulatory pumps comprising ambIT infusion pumps for the delivery of medications and pain relief; DOSI-FUSER, a portable elastomeric pump; DOSI-PAIN, a wound catheter for postoperative continuous infusion; and Springfusor, a syringe infusion pump, as well as syringe and volumetric pumps. Further, the company offers Amnicot, a rubber latex finger cot; NASAL PCA, an activated nasal spray for the administration of drugs to the nasal mucosa; and O'Neil Urinary Catheter, a single use disposable device used to catheterise the patient without the need for an extensive sterile field. Additionally, it develops vaccines for the treatment and prevention of infectious diseases and cancers focusing on Herpes Simplex Virus and Human Papillomavirus (HPV). The company was formerly known as Allied Healthcare Group Limited and changed its name to Admedus Limited in November 2013. Admedus Limited is based in Toowong, Australia.
Medicine Healthcare Pain Equipment Infectious Diseases Medical Technology Cancers Medical Equipment Regenerative Medicine Dosage Forms Pump Catheter Hpv Syringe Cannula Medical Technologies